1. Home
  2. BMRN vs WTRG Comparison

BMRN vs WTRG Comparison

Compare BMRN & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • WTRG
  • Stock Information
  • Founded
  • BMRN 1996
  • WTRG 1901
  • Country
  • BMRN United States
  • WTRG United States
  • Employees
  • BMRN N/A
  • WTRG N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • WTRG Water Supply
  • Sector
  • BMRN Health Care
  • WTRG Utilities
  • Exchange
  • BMRN Nasdaq
  • WTRG Nasdaq
  • Market Cap
  • BMRN 12.1B
  • WTRG 11.1B
  • IPO Year
  • BMRN 1999
  • WTRG N/A
  • Fundamental
  • Price
  • BMRN $59.82
  • WTRG $40.61
  • Analyst Decision
  • BMRN Buy
  • WTRG Strong Buy
  • Analyst Count
  • BMRN 22
  • WTRG 6
  • Target Price
  • BMRN $93.43
  • WTRG $43.50
  • AVG Volume (30 Days)
  • BMRN 1.6M
  • WTRG 1.3M
  • Earning Date
  • BMRN 05-01-2025
  • WTRG 05-12-2025
  • Dividend Yield
  • BMRN N/A
  • WTRG 3.17%
  • EPS Growth
  • BMRN 152.82
  • WTRG 16.67
  • EPS
  • BMRN 2.71
  • WTRG 2.17
  • Revenue
  • BMRN $2,950,227,000.00
  • WTRG $2,086,113,000.00
  • Revenue This Year
  • BMRN $12.27
  • WTRG $14.33
  • Revenue Next Year
  • BMRN $9.86
  • WTRG $6.96
  • P/E Ratio
  • BMRN $22.11
  • WTRG $18.92
  • Revenue Growth
  • BMRN 19.36
  • WTRG 1.57
  • 52 Week Low
  • BMRN $52.93
  • WTRG $33.18
  • 52 Week High
  • BMRN $94.85
  • WTRG $41.78
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 40.34
  • WTRG 54.12
  • Support Level
  • BMRN $60.92
  • WTRG $40.24
  • Resistance Level
  • BMRN $65.40
  • WTRG $41.60
  • Average True Range (ATR)
  • BMRN 1.96
  • WTRG 0.78
  • MACD
  • BMRN 0.06
  • WTRG -0.03
  • Stochastic Oscillator
  • BMRN 21.52
  • WTRG 51.47

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About WTRG Essential Utilities Inc.

Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024.

Share on Social Networks: